On Tuesday, Marsh & McLennan received a positive adjustment to its Relative Strength (RS) Rating, from 70 to 73.
This unique rating identifies market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the trailing 52 weeks compares to other publicly traded companies.
Over 100 years of market history shows that the stocks that go on to make the biggest gains typically have an RS Rating of above 80 as they launch their biggest price moves. See if Marsh & McLennan can continue to show renewed price strength and hit that benchmark.
Can You Really Time The Stock Market?
Marsh & McLennan is working on a cup without handle with a 235.50 buy point. See if it can break out in volume at least 40% above average.
Top and bottom line growth moved higher last quarter. Earnings were up 11%, compared to 4% in the prior report. Revenue increased from 6% to 9%.
Marsh & McLennan holds the No. 5 rank among its peers in the Insurance-Brokers industry group. Ryan Specialty Holdings is the top-ranked stock within the group.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
